  |
 | Up a level |
Hawkins, Robert E. and Gore, Martin and Shparyk, Yaroslav and Bondar, Vladimir and Gladkov, Oleg and Ganev, Tosho and Harza, Mihai and Polenkov, Serhii and Bondarenko, Igor and Karlov, Petr and Karyakin, Oleg and Khasanov, Rustem and Hedlund, Gunnar and Forsberg, Goran and Nordle, Orjan and Eisen, Timothy (2016) A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis. Clinical Cancer Research, 22 (13). pp. 3172-3181. ISSN 1078-0432 (print), 1557-3265 ( online)
Garnett, Sally and Martin, Miguel and Jerusalem, Guy and Petruzelka, Lubos and Torres, Roberto and Bondarenko, Igor N. and Khasanov, Rustem and Verhoeven, Didier and Pedrini, José L. and Smirnova, Iya and Lichinitser, Mikhail R. and Pendergrass, Kelly and Lindemann, Justin P.O. and Di Leo, Angelo (2011) Application of new methodology to allow comparison of duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial. The Breast, V. 20 (Sup. 4). S45. ISSN 0960-9776
